跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75,178 条关于
“B cell-derived malignancies”
全部
75,178
临床试验
49,480
药物
6,792
机构
3,235
资讯
15,671
去年
BTK Degraders Show Promise in Pretreated B-Cell Malignancies
2年前
Emerging BTK Degraders Show Promise in Treating Resistant B-Cell Malignancies
去年
CAR-T Therapies AT-19 and XYF-19 Show Promise in Treating B-Cell Lymphomas
2年前
Off-The-Shelf Allogeneic CAR-T Therapies Show Promise for B-Cell Malignancies
2个月前
Nurix Therapeutics Pipeline Review: BTK Degraders and Targeted Protein Degradation Advance in B-Cell Malignancies
去年
Glenmark Pharmaceuticals Receives DCGI Approval to Launch BRUKINSA for Five B-Cell Malignancies in India
8个月前
Ascentage Pharma Receives FDA Clearance for Novel BTK Protein Degrader APG-3288 in B-Cell Malignancies
去年
Schrödinger to Present Phase 1 Data on MALT1 Inhibitor SGR-1505 for Relapsed/Refractory B-Cell Malignancies
10个月前
Genmab Presents Pivotal Phase 3 Data for Epcoritamab at ASH 2025, Expanding Treatment Options Across B-Cell Malignancies
9个月前
ALETA-001 Shows Promise in Phase I/II Trial for Relapsed B-Cell Malignancies After CAR-T Therapy
第 1 页，共 1568 页
上一页
下一页
